Logo image

Eyetronic Optic Nerve Stimulation Therapy - Restoring Vision & Visual Field | Germany

Eyetronic Optic Nerve Stimulation Therapy - Restoring Vision & Visual Field | Germany
9.30

Berlin, Germany

13
User ScoreRatingMedia Files
96%9.3/1013

Overview

Age group

Adults

Type of care

Outpatient

Method

No surgery

About the offer

EYETRONIC Therapy is a non-invasive electrical stimulation treatment developed for patients experiencing visual field loss due to glaucoma or other optic nerve disorders. The procedure uses individually adjusted alternating-current pulses delivered through special stimulation goggles. An EEG cap records brain activity while the treatment team monitors the stimulation process. The system for treating visual field loss is a CE-certified medical device, in accordance with EU regulations. So far, over 1200 patients have been treated with the EYETRONIC Therapy. In about 63% of treated eyes, visual field loss progression could be stopped, or visual field improvement could be observed at the one-year follow-up. The ONS therapy can therefore be a good option to treat visual field loss in glaucomatous progression. The therapy aims to stimulate surviving retinal ganglion cells and support recovery or stabilization of visual field function. It may be considered for selected patients whose optic nerve damage has left viable nerve cells. Treatment suitability depends on the underlying condition and the patient's clinical findings. Results vary, and improvement cannot be guaranteed. The therapy should not replace standard glaucoma treatment or other necessary ophthalmological care. The therapy is based on the knowledge that tissue is not always completely destroyed when the optic nerve is damaged. Many cells survive but are malfunctioning. Innovative optic nerve stimulation (ONS) has a twofold effect: first, so-called neuroprotection prevents further degeneration of retinal ganglion cells. This protective effect also underpins the second effect, so-called neurorestoration. Through targeted rhythmic current stimuli, the metabolism of nerve cells is stimulated, protecting them from further degeneration and supporting the recovery of neuronal function. The system consists of an electrical stimulator and a high-precision EEG amplifier, together forming the Patient Unit. Control electronics enable the communication between the two components of the Patient Unit. The patient wears special goggles and an EEG cap connected to the Patient Unit. The therapist monitors the treatment via a Supervisor Unit and adjusts it to individual patient needs based on the perception of phosphenes. The treatment consists of ten sessions held on ten consecutive business days. One session takes about 60 minutes, including preparation. Some glaucoma patients continue to suffer from progressive visual field loss, despite therapeutic lowering of the intraocular pressure. For this group, innovative neuroprotective therapies, such as electrical optic nerve stimulation (ONS), are indicated. Preclinical studies and clinical data have demonstrated their safety and efficacy. A recent study collected long-term perimetry results after ONS. 70 glaucoma patients aged between 45 and 86 years, who showed a progressive visual field loss despite therapeutic lowering of the intraocular pressure ≤18 mmHg, were treated with ONS. We stimulated the optic nerve transcutaneously on both sides until phosphenes were perceived (max. 1. 2 mA; 5-34 Hz). Immediately before ONS therapy and about 1 year after, we performed standard white/white threshold perimetry of the central visual field (Octopus 300, 30°). We defined mean defect (MD) as the primary outcome parameter. We conducted follow-up perimetry in 70 patients with 101 eyes 362±45 days (mean±SD) after ONS therapy. 64 eyes in 49 patients showed no further disease progression and, in some cases, improvement after one year.

What’s included

Medical service

Examination
  • medical records review
  • ophthalmological consultation
  • qualification for therapy
Diagnosis
  • baseline visual field assessment
  • OCT
  • intraocular pressure measurement
  • visual acuity testing
  • other assessments (when clinically indicated)
Treatment
  • 10 EYETRONIC® stimulation sessions (a complete course of individualized optic nerve stimulation, generally delivered over 10 consecutive working days)
  • adaptation of stimulation parameters to the patient's responses and the treatment protocol
  • use of the EEG cap, stimulation goggles, and monitoring equipment during treatment
  • review of the treatment course, repeat visual field testing where appropriate

Extra add-ons

Parking Space
Digital Health Records

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Meet the provider

Prof. Dr. med. Carl Erb

glaucoma, neurodegenerative ophthalmology

9.30
Excellent

Gallery

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

FAQ

What is Eyetronic therapy about?

This almost painless, low-risk therapy is based on the fact that tissue isn't always completely destroyed when the optic nerve is damaged. Many cells survive but are malfunctioning. By applying gentle electrical pulses, the therapy stimulates neuronal metabolism to restore function and stop further cell degeneration.

How is the therapy applied?

The therapy consists of ten sessions of about 60 minutes each, applied on ten consecutive business days. Special goggles electrically stimulate the optic nerve. The therapist customizes the treatment to each patient and controls the process on a monitor.

Who is Eyetronic therapy suitable for?

The therapy was developed for patients with visual field loss due to glaucoma or other optic nerve diseases.

Which symptoms may indicate visual field loss?

Symptoms vary from patient to patient and may include black and bright spots, blurred vision, partial visual field defects, and loss of close-range and distance vision.

How effective is the therapy?

A clinical study showed that patients treated with the therapy experienced improved vision. Long-term data further showed that Eyetronic therapy can be a good option to treat visual field loss in glaucomatous progression.

What is the rating of the offer?

Eyetronic Optic Nerve Stimulation Therapy - Restoring Vision & Visual Field | Germany is rated as 9.30 by AiroMedical.

Who is offering a deal?

The provider is Prof. Dr. med. Carl Erb.

How long does the offer take?

The offer is designed for 14 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible only for adults.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Does the offer include extra services?

Eyetronic Optic Nerve Stimulation Therapy - Restoring Vision & Visual Field | Germany has 2 add-ons and unique AiroCare services for AiroMedical users.

Individual cost estimate. Non-binding 100% free assessment.

On request

Similar deals